BioTech News and Headlines

3 Top Challenges Facing Regulatory Professionals Right Now
NewsFeb 5, 2026

3 Top Challenges Facing Regulatory Professionals Right Now

Regulatory professionals are grappling with three pressing challenges: vague FDA and EMA AI guidance, the mismatch between rapidly evolving AI models and static regulatory frameworks, and a constrained supply chain for radiopharmaceuticals. Experts stress that AI‑driven submissions must rest on...

By BioSpace
Employers Warm Up to Remote Workers Again: BioSpace Report
NewsFeb 5, 2026

Employers Warm Up to Remote Workers Again: BioSpace Report

Biopharma employers are warming to remote hiring again, with 28% saying they will recruit candidates regardless of location in 2026 – up from 20% in 2024 and 16% in 2023. The share of firms focused solely on local talent fell...

By BioSpace
IRF5’s Role in Emphysema via NLRP3 and Ly6C Cells
NewsFeb 5, 2026

IRF5’s Role in Emphysema via NLRP3 and Ly6C Cells

Researchers identified IRF5 as a central driver of emphysema by linking it to heightened NLRP3 inflammasome activity and accumulation of Ly6C‑expressing monocytes in lung tissue. Human samples and mouse models showed elevated IRF5 expression correlating with increased pro‑inflammatory cytokines and...

By Bioengineer.org
Free Halide Ions Enable Switchable Photoluminescence
NewsFeb 5, 2026

Free Halide Ions Enable Switchable Photoluminescence

Researchers have demonstrated that substituting free halide ions in manganese‑based metal halides can reversibly switch photoluminescence intensity and wavelength. The ion‑substitution mechanism alters the local coordination around Mn ions, modulating exciton dynamics and radiative pathways. The switching is repeatable over...

By Bioengineer.org
Leadership’s Impact on Allied Health Professional Identity
NewsFeb 5, 2026

Leadership’s Impact on Allied Health Professional Identity

The 2026 BMC Health Services Research study by Hales, Achour and King investigates how leadership shapes the professional identity of allied health workers. It argues that purpose‑driven mentorship, shared leadership, and values‑based guidance improve job satisfaction, reduce burnout, and enhance...

By Bioengineer.org
Sarepta Saga Has 'Gone on Too Long' As Competitors Catch Up
NewsFeb 5, 2026

Sarepta Saga Has 'Gone on Too Long' As Competitors Catch Up

Sarepta Therapeutics’ one‑time gene therapy Elevidys, priced at $3.2 million, is under intense scrutiny after three patient deaths in 2025 and a steep 80% stock decline. The company’s three‑year efficacy data failed to reassure analysts, and quarterly sales missed expectations, leaving...

By BioSpace
Natto: Unveiling the Surprising Science Behind This Unconventional Superfood
NewsFeb 5, 2026

Natto: Unveiling the Surprising Science Behind This Unconventional Superfood

A study led by Professor Hideshi Ihara at Osaka Metropolitan University discovered that the fermentation of soybeans into natto dramatically increases supersulfide molecules, a class of sulfur metabolites linked to cellular health. The research showed that heat‑treated soybeans further amplify...

By Bioengineer.org
A Groundbreaking Innovation Revolutionizes Medical Device Technology
NewsFeb 5, 2026

A Groundbreaking Innovation Revolutionizes Medical Device Technology

A new medical device merges artificial intelligence with nanoscopic biosensor arrays, enabling real‑time, minimally invasive diagnostics at the cellular level. The integrated AI interprets biomarker signals instantly, delivering results in seconds and supporting continuous monitoring of chronic diseases. Manufacturing leverages...

By Bioengineer.org
AI Foundation Model Aims to Make Stem Cell Therapies More Predictable
NewsFeb 5, 2026

AI Foundation Model Aims to Make Stem Cell Therapies More Predictable

Harvard Medical School researchers have spun out Cellular Intelligence to create a foundation model that predicts stem‑cell behavior and scales production. The company leverages massive high‑throughput capsule experiments to train a machine‑learning system on developmental biology data. By uncovering the...

By Phys.org – Biotechnology
Enhancing Teamwork in Acute Care: A Mixed-Methods Study
NewsFeb 5, 2026

Enhancing Teamwork in Acute Care: A Mixed-Methods Study

A recent mixed‑methods study examined how interdisciplinary teamwork functions in acute‑care settings, combining surveys, observations, and staff interviews. Researchers identified communication gaps, role ambiguity, and workflow bottlenecks that hinder rapid decision‑making. Quantitative data showed a 12% reduction in adverse events...

By Bioengineer.org
Menstrual Blood Testing for HPV Shows Promise as a Reliable Alternative to Cervical Screening
NewsFeb 5, 2026

Menstrual Blood Testing for HPV Shows Promise as a Reliable Alternative to Cervical Screening

A BMJ‑published study of 3,068 Chinese women demonstrates that menstrual‑blood HPV testing matches or exceeds clinician‑collected cervical samples, achieving 94.7% sensitivity for CIN2+ lesions. The method uses a sterile minipad to collect menstrual blood, integrates results via a WeChat‑based app,...

By Bioengineer.org
136 Schools Nationwide Receive Grants to Advance Student and Faculty Health Research
NewsFeb 5, 2026

136 Schools Nationwide Receive Grants to Advance Student and Faculty Health Research

The American Heart Association and the NFL have launched a $350,000 annual grant program, awarding 136 schools across the United States to boost student and faculty health research. The initiative expands the Kids Heart Challenge, American Heart Challenge, and NFL...

By Bioengineer.org
Dialing Out the Hallucinogenic Effect of Psychedelics — BioCentury’s Science Spotlight
NewsFeb 5, 2026

Dialing Out the Hallucinogenic Effect of Psychedelics — BioCentury’s Science Spotlight

Researchers at Sichuan University have identified distinct signaling pathways that separate the hallucinogenic and therapeutic actions of psychedelic compounds. By comparing classic psychedelics with non‑hallucinogenic analogues, they showed that 5‑HT2A‑mediated non‑canonical Gi signaling drives hallucinations, while canonical Gq signaling underlies...

By BioCentury
The Role of Neural Derived Extracellular Vesicles Micro-Ribonucleic Acid Cargo in White Matter Integrity in Early-Onset and Late-Onset Bipolar Disorder
NewsFeb 5, 2026

The Role of Neural Derived Extracellular Vesicles Micro-Ribonucleic Acid Cargo in White Matter Integrity in Early-Onset and Late-Onset Bipolar Disorder

Recent research isolates neural‑derived extracellular vesicles (EVs) from plasma of bipolar disorder patients and maps their micro‑RNA (miRNA) cargo, revealing distinct profiles for early‑onset versus late‑onset cases. Specific miRNAs, such as miR‑211‑5p, miR‑34a and miR‑425‑5p, correlate with diffusion tensor imaging...

By Nature (Biotechnology)
Cutting-Edge Discoveries From MSK Research – February 4, 2026
NewsFeb 4, 2026

Cutting-Edge Discoveries From MSK Research – February 4, 2026

Memorial Sloan Kettering researchers mapped the lineage of rare Thetis immune cells, showing they arise from fetal liver TLP progenitors and depend on RANKL signals during the weaning window. A parallel study revealed that the order of antigen recognition and...

By Bioengineer.org
Asking Amgen to Withdraw Tavneos, FDA Revisits Years-Old Data Issue
NewsFeb 4, 2026

Asking Amgen to Withdraw Tavneos, FDA Revisits Years-Old Data Issue

The FDA has asked Amgen to withdraw its vasculitis drug Tavneos (avacopan) after re‑examining a data‑interpretation issue that was central to the advisory committee’s split vote before its 2021 approval. Amgen, which acquired Tavneos through its $4 billion purchase of ChemoCentryx...

By BioCentury
Indolent Cutaneous B-Cell Lymphomas Mimic Persistent Antigen Reactions
NewsFeb 4, 2026

Indolent Cutaneous B-Cell Lymphomas Mimic Persistent Antigen Reactions

Researchers publishing in Nature Communications have shown that indolent primary cutaneous B‑cell lymphomas (PCBCLs) closely resemble persistent antigen‑driven immune reactions rather than undergoing dedifferentiation. Advanced transcriptomic and single‑cell analyses revealed gene‑expression patterns and active B‑cell receptor signaling that mirror chronic...

By Bioengineer.org
UT Health San Antonio Scientists Author American Heart Association Statement on Early Detection and Treatment of Post-Stroke Spasticity
NewsFeb 4, 2026

UT Health San Antonio Scientists Author American Heart Association Statement on Early Detection and Treatment of Post-Stroke Spasticity

Scientists from UT Health San Antonio authored an American Heart Association scientific statement urging early detection and treatment of post‑stroke spasticity. The document highlights that 30‑80% of stroke survivors develop the condition and that interventions within the first three months...

By Bioengineer.org
Quick Test Can Curb Antimicrobial Resistance, Identifying Bacteria and Antibiotic Susceptibility in Under 40 Minutes
NewsFeb 4, 2026

Quick Test Can Curb Antimicrobial Resistance, Identifying Bacteria and Antibiotic Susceptibility in Under 40 Minutes

McGill researchers unveiled QolorPhAST, a compact diagnostic that identifies bacterial species and determines antibiotic susceptibility in just 36 minutes, dramatically faster than the conventional 48‑72‑hour culture methods. The system leverages nanoplasmonic colorimetric sensors, microfluidic channels, and machine‑learning image analysis to...

By Phys.org – Nanotechnology
How Lipid Nanoparticles Carrying Vaccines Release Their Cargo
NewsFeb 4, 2026

How Lipid Nanoparticles Carrying Vaccines Release Their Cargo

Researchers at Friedrich‑Alexander University Erlangen‑Nürnberg have simulated how lipid nanoparticles used in mRNA vaccines release their cargo within acidic endosomes. Their computer models show that amino lipids become positively charged at specific pKa values, causing membrane destabilization and cargo discharge....

By Phys.org – Nanotechnology
FTC Settles Insulin Lawsuit with Express Scripts
NewsFeb 4, 2026

FTC Settles Insulin Lawsuit with Express Scripts

The Federal Trade Commission reached a settlement with pharmacy‑benefit manager Express Scripts over its handling of insulin rebates, securing an agreement that extends across virtually every segment of the company’s operations. The deal requires changes to rebate structures, increased transparency,...

By Endpoints News
AbbVie Says Immunology Blockbusters Will Be 'Main Drivers' Of Growth Post-Humira
NewsFeb 4, 2026

AbbVie Says Immunology Blockbusters Will Be 'Main Drivers' Of Growth Post-Humira

AbbVie announced that its newer immunology drugs are compensating for the imminent loss of Humira’s patent protection. The combined sales of Skyrizi and Rinvoq have already surpassed Humira’s historic peak, signaling a successful transition to next‑generation biologics. The company frames...

By Endpoints News
Nanocrystal Biohybrids Harvest Light to Reduce N₂ Gas to Ammonia
NewsFeb 4, 2026

Nanocrystal Biohybrids Harvest Light to Reduce N₂ Gas to Ammonia

Researchers at the National Laboratory of the Rockies and partner universities created a nanocrystal‑biohybrid that uses cadmium sulfide quantum dots to harvest light and supply electrons to a molybdenum‑iron (MoFe) nitrogenase protein, driving the conversion of atmospheric N₂ into ammonia....

By Phys.org – Nanotechnology
Lab-Grown Beef: Novel Line of Bovine Embryonic Stem Cells Shows Promise
NewsFeb 4, 2026

Lab-Grown Beef: Novel Line of Bovine Embryonic Stem Cells Shows Promise

Researchers at UConn's College of Agriculture, Health and Natural Resources have created a novel bovine embryonic stem cell (ESC) line that remains pluripotent without genetic modification. The cells were derived from blastocysts and cultured in a proprietary medium that outperforms...

By Phys.org – Biotechnology
Even Endpoint Hits Don’t Spare Shares in Three Weight-Loss Updates
NewsFeb 4, 2026

Even Endpoint Hits Don’t Spare Shares in Three Weight-Loss Updates

Three leading obesity‑drug developers announced trials that met primary weight‑loss endpoints, yet their shares fell sharply. Novo Nordisk’s semaglutide extension hit its target but stock slipped amid pricing concerns. Eli Lilly’s tirzepatide data showed robust reductions, yet investors worried about market...

By BioCentury
Rare Pediatric PRV Program Reauthorized Until 2029 via Government Funding Law
NewsFeb 4, 2026

Rare Pediatric PRV Program Reauthorized Until 2029 via Government Funding Law

President Donald Trump signed a government funding extension that also reauthorizes the FDA’s rare pediatric priority review voucher (PRV) program through 2029. The legislation revives the incentive mechanism that awards vouchers to sponsors of approved treatments for rare pediatric diseases,...

By Endpoints News
BDC Head Says Bank Pulled Back From Life Sciences “Too Early” As It Preps New VC Fund
NewsFeb 4, 2026

BDC Head Says Bank Pulled Back From Life Sciences “Too Early” As It Preps New VC Fund

The Business Development Bank of Canada (BDC) is preparing a new life‑sciences fund of roughly C$100 million to re‑enter direct medtech investing, launching before April. BDC’s president Isabelle Hudon said the bank withdrew from the sector too early after its 2013...

By BetaKit (Canada)
OpenScholar AI Model Achieves Human-Level Accuracy in Synthesizing and Citing Scientific Research
NewsFeb 4, 2026

OpenScholar AI Model Achieves Human-Level Accuracy in Synthesizing and Citing Scientific Research

OpenScholar, a new AI model from the University of Washington and the Allen Institute for AI, leverages a 45‑million‑paper corpus and retrieval‑augmented generation to synthesize scientific literature with human‑level accuracy. In benchmark testing on ScholarQABench, it outperformed GPT‑4o and Meta...

By Bioengineer.org
AI Tool Promises to Pinpoint Which Men Over 60 with Prostate Cancer Need Follow-Up
NewsFeb 4, 2026

AI Tool Promises to Pinpoint Which Men Over 60 with Prostate Cancer Need Follow-Up

Researchers at Norway’s NTNU unveiled PROVIZ, an AI‑driven tool that analyzes prostate MRI scans to identify lesions needing biopsy in men over 60. Early testing at St Olavs Hospital showed the system can flag suspicious areas with higher sensitivity, potentially reducing...

By Bioengineer.org
New Transgenic Zebrafish Model Accelerates Decades of Muscle Atrophy Research Into Weeks
NewsFeb 4, 2026

New Transgenic Zebrafish Model Accelerates Decades of Muscle Atrophy Research Into Weeks

Researchers have unveiled a transgenic zebrafish model that mimics human muscle atrophy with unprecedented speed, compressing experiments that traditionally took months into a matter of weeks. The fish express a muscle‑specific, inducible atrophy gene, allowing precise temporal control and high‑throughput...

By Bioengineer.org
AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas
NewsFeb 4, 2026

AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas

AbbVie’s immunology portfolio generated roughly $30 billion in 2025, accounting for nearly half of its $61.1 billion total sales, driven by Skyrizi, Rinvoq and residual Humira revenue. Executives used the earnings call to spotlight under‑appreciated neuroscience and oncology assets, highlighting Parkinson’s drug...

By BioSpace
Cracking the Rules of Gene Regulation with Experimental Elegance and AI
NewsFeb 4, 2026

Cracking the Rules of Gene Regulation with Experimental Elegance and AI

Scientists at the Netherlands Cancer Institute unveiled PARM, a lightweight deep‑learning model that accurately predicts gene‑regulatory activity across cell types. By coupling millions of high‑precision experimental measurements with AI, the team decoded the DNA “on‑off” language that governs gene expression....

By Phys.org – Biotechnology
Case Western Reserve Professor Develops Innovative Card Deck to Help Kids Manage Stress Effectively
NewsFeb 4, 2026

Case Western Reserve Professor Develops Innovative Card Deck to Help Kids Manage Stress Effectively

Case Western Reserve University associate professor Jennifer King has launched the “Take a Break KIDS” micro‑practice card deck, a child‑friendly adaptation of her adult stress‑management tool. The deck features 40 color‑coded cards covering movement, breath, self‑touch, and partner activities, each...

By Bioengineer.org
Pigs and Grizzlies, Not Monkeys, Unlock Secrets of Youthful Human Skin
NewsFeb 4, 2026

Pigs and Grizzlies, Not Monkeys, Unlock Secrets of Youthful Human Skin

Washington State University researchers discovered that human‑like rete ridges develop after birth, driven by bone morphogenetic protein (BMP) signaling, using pigs and grizzly bears as comparative models. This overturns the long‑held belief that these skin microstructures form only prenatally. The...

By Bioengineer.org
University of Galway Launches New Prototype Hub in Partnership with Medtronic
NewsFeb 4, 2026

University of Galway Launches New Prototype Hub in Partnership with Medtronic

The University of Galway has opened a Medical Device Prototype Hub in partnership with Medtronic, marking a key milestone in their five‑year, €5 million innovation agreement. The hub, housed within the university’s Technology Services Directorate, provides rapid prototyping, 3D printing, and...

By Irish Tech News
Nanobodies: A Cure for Treatment-Resistant Depression Depression?
NewsFeb 4, 2026

Nanobodies: A Cure for Treatment-Resistant Depression Depression?

Researchers at the University of Miami have engineered a nanobody, Nb20, that selectively inhibits the metabotropic glycine receptor (mGlyR), a newly identified driver of depression. In rodent models, a single intranasal dose produced rapid antidepressant‑like behavior comparable to ketamine, with...

By Phys.org – Nanotechnology
Racial-Ethnic Gaps in Preterm Infant Growth
NewsFeb 4, 2026

Racial-Ethnic Gaps in Preterm Infant Growth

A recent study highlights persistent racial‑ethnic disparities in the growth trajectories of preterm infants, revealing that Black and Hispanic newborns gain weight and length more slowly than their White counterparts. The analysis, based on a national cohort of over 10,000...

By Bioengineer.org
Midi Health Raises $100M as It Plans Expansion Into Urgent Care, Research
NewsFeb 4, 2026

Midi Health Raises $100M as It Plans Expansion Into Urgent Care, Research

Midi Health, the pandemic‑born women’s health platform, announced a $100 million financing round that pushes its valuation past the $1 billion unicorn threshold. The capital, led by a consortium of venture firms, will fund the launch of a nationwide urgent‑care network and...

By Endpoints News
Hims Adds Grail's Cancer Test Amid Questions About Widespread Use
NewsFeb 4, 2026

Hims Adds Grail's Cancer Test Amid Questions About Widespread Use

Hims & Hers, the telehealth consumer‑health brand, announced a partnership with Grail to offer the Galleri multi‑cancer early‑detection blood test on its platform. The move brings a technology that can screen for more than 50 cancer types to a broader,...

By Endpoints News
Making Healthcare Better: The Manufacturing Technologies Powering MedTech Innovation
NewsFeb 4, 2026

Making Healthcare Better: The Manufacturing Technologies Powering MedTech Innovation

Stryker highlights how advanced manufacturing, robotics, AI and digital twins are reshaping MedTech, accelerating product cycles and enabling patient‑specific solutions. Additive manufacturing and 3D printing now move concepts to production in weeks, while digital twins create precise virtual replicas for...

By Irish Tech News
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods
NewsFeb 4, 2026

Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods

Amgen is positioning its investigational bispecific antibody‑peptide, MariTide, as a differentiated obesity therapy by offering monthly, bimonthly, or quarterly dosing without compromising efficacy. Phase II data revealed an average weight loss of up to 20 % after 52 weeks, and the company...

By BioSpace
The Biggest Biotech Funding Rounds in January 2026
NewsFeb 4, 2026

The Biggest Biotech Funding Rounds in January 2026

In January 2026 biotech firms secured record capital, with Parabilis Medicines leading private rounds at $305 million and Aktis Oncology topping public offerings at $365.4 million. Private fundraising totaled $2.986 billion across 31 rounds, while public markets raised $1.67 billion from nine offerings. Oncology and...

By Labiotech.eu
Oracle Life Sciences AI Data Platform Unites Data and Agentic Intelligence to Accelerate Medical Breakthroughs
NewsFeb 4, 2026

Oracle Life Sciences AI Data Platform Unites Data and Agentic Intelligence to Accelerate Medical Breakthroughs

Oracle introduced the Oracle Life Sciences AI Data Platform, a generative AI‑enabled solution that consolidates diverse life‑science datasets and applies agentic AI to accelerate research, clinical trials, and commercialization. The platform offers out‑of‑the‑box AI agents and tools for label expansion,...

By Database Trends & Applications (DBTA)
HighRes and Opentrons Announce Partnership to Launch AI Agent-to-Agent Lab Automation Workflow
NewsFeb 4, 2026

HighRes and Opentrons Announce Partnership to Launch AI Agent-to-Agent Lab Automation Workflow

HighRes and Opentrons have formed a strategic partnership to create the industry’s first AI agent‑to‑agent laboratory automation workflow, linking software‑driven experiment design directly to physical execution. The integration combines Opentrons’ modular robotic platforms and AI‑enabled protocol tools with HighRes’ orchestration...

By The AI Insider
GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity
NewsFeb 4, 2026

GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity

GSK’s new CEO Luke Miels announced the company will not pursue GLP‑1 obesity drugs, citing a crowded market and pipeline misalignment. Instead, GSK is concentrating on the downstream complications of obesity, particularly liver disease, after acquiring Boston Pharmaceuticals’ efimosfermin alfa...

By BioSpace
Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4
NewsFeb 4, 2026

Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4

Eli Lilly reported fourth‑quarter revenue of $19.3 billion, driven by a 46 % surge in volume of its GLP‑1 drugs Mounjaro and Zepbound. Earnings per share rose to $7.54, comfortably beating the $6.91 consensus. The two drugs together generated $11.7 billion, lifting the company’s...

By BioSpace
Green Chemistry Breakthrough: Friendly Bacteria Reveal Hidden Metabolic Pathways in Plant Cell Cultures
NewsFeb 4, 2026

Green Chemistry Breakthrough: Friendly Bacteria Reveal Hidden Metabolic Pathways in Plant Cell Cultures

Scientists at Tokyo University of Science have shown that endophytic bacteria can coexist with plant cell cultures and unlock dormant metabolic pathways. Co‑culturing tobacco BY‑2 cells with Delftia sp. BR1R‑2 triggered a surge in acetophenone derivatives and altered phenolic profiles...

By Bioengineer.org
QT Sense Secures €4M ($4.7M USD) for Nanodiamond-Based Cellular Sensing Platform
NewsFeb 4, 2026

QT Sense Secures €4M ($4.7M USD) for Nanodiamond-Based Cellular Sensing Platform

QT Sense, a Dutch biotech startup, closed a €4 million seed round led by Cottonwood Technology Fund, supplemented by an ONCO‑Q grant and the Quantum Forward Challenge. The capital will accelerate development of Quantum Nuova, a nanodiamond‑based quantum‑sensing platform that provides real‑time,...

By Quantum Computing Report
Women in STEM: Cultivating Scientific Confidence
NewsFeb 4, 2026

Women in STEM: Cultivating Scientific Confidence

Elisabeth Gardiner, CSO of Tevard Biosciences, warned that women remain vastly under‑represented in pharmaceutical STEM roles, occupying only 20‑30% of such positions despite comprising half of the U.S. workforce. She highlighted a "confidence paradox" where girls' interest in STEM has...

By Pharmaceutical Technology